Streetbeat News

BCAN

BYND Cannasoft Enterprises Inc.

https://www.cannasoft-crm.com

Industry

Software - Infrastructure

BYND Cannasoft Enterprises Inc. develops, markets, and sells customer relationship management (CRM) software products. It owns and markets Benefit CRM, a customer relationship management software product that enables small and medium-sized enterprises to optimize day-to-day functions, such as sales management, workforce management, contact center operations, and asset management; and New Cannabis CRM platform for the medical cannabis industry, as well as manages the construction, licensing, and operation of a cannabis farm and indoor cannabis growing facility. The company is based in Vancouver, Canada.

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

Femto Technologies Inc. (NASDAQ:BCAN) shares are declining after the company announced a 1-for-17 reverse stock split to meet Nasdaq's minimum bid price requirement. The stock is down 4.32% at $8.65.

Portfolio Pulse from Dylan Berman

August 26, 2024 | 6:07 pm

Femto Technologies' shares are trading lower following the completion of a 1-for-17 reverse stock split.

Portfolio Pulse from Benzinga Newsdesk

August 26, 2024 | 3:22 pm

The trading halt status was updated at 8:55:00 AM ET, indicating a quotation resumption. This update is crucial for investors tracking the affected stocks.

Portfolio Pulse from Benzinga Newsdesk

August 26, 2024 | 12:55 pm

Trading for BCAN was halted at 7:50:00 p.m. ET due to pending news. This indicates that significant information regarding the company is expected to be released, which could impact its stock price.

Portfolio Pulse from Benzinga Newsdesk

August 23, 2024 | 11:50 pm

Virios Therapeutics shares fell 47.6% after pricing a $1.7 million public offering. Other notable movers include MultiMetaVerse Holdings, GT Biopharma, and Faraday Future Intelligent Electric, among others.

Portfolio Pulse from Avi Kapoor

May 20, 2024 | 5:28 pm

Cannabis stocks are experiencing an uptick after reports surfaced that the DEA is considering reclassifying marijuana to a less restrictive drug category. This potential shift suggests a more favorable regulatory environment for cannabis companies, potentially increasing their market opportunities and reducing legal barriers.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 5:10 pm

Agenus Inc. experienced a significant drop of 17% in its stock price after announcing a 1-for-20 reverse stock split. Other stocks also showed notable movements, with Auddia Inc. surging 231.7% following a new U.S. patent award, and Longeveron Inc. climbing 93.2% after submitting paperwork for a share offering. UTime Limited, U Power Limited, and several other companies also saw significant gains. Conversely, 22nd Century Group Inc. and Perion Network Ltd. were among the top losers, with sharp declines in their stock prices.

Portfolio Pulse from Avi Kapoor

April 08, 2024 | 5:10 pm

Esperion Therapeutics shares rose by 7.1% in pre-market trading after presenting new data from CLEAR outcomes at ACC.24, highlighting the value of NEXLETOL tablets. Other stocks also showed significant movement in pre-market trading, with Longeveron Inc. leading the gainers and 22nd Century Group, Inc. leading the losers.

Portfolio Pulse from Avi Kapoor

April 08, 2024 | 9:15 am

Ulta Beauty, Inc. (ULTA) shares fell by 13.7% following a weak outlook presented at the J.P. Morgan Retail Roundup. Other stocks experienced significant movements, with ARCA biopharma, Inc. (ABIO) and Kintara Therapeutics, Inc. (KTRA) seeing substantial gains due to merger agreements. Vanda Pharmaceuticals Inc. (VNDA) and VivoPower International PLC (VVPR) also saw notable increases. On the downside, Casa Systems, Inc. (CASA) and View, Inc. (VIEW) plummeted after filing for Chapter 11 bankruptcy.

Portfolio Pulse from Avi Kapoor

April 03, 2024 | 5:56 pm

Cal-Maine Foods, Inc. (NASDAQ:CALM) shares rose by 8.3% in pre-market trading after reporting Q4 earnings of $3.00 per share, surpassing the consensus estimate of $2.46. Other stocks also showed significant movement in pre-market trading, with LAMF Global Ventures Corp. I (NASDAQ:LGVC) and Aesthetic Medical International Holdings Group Limited (NASDAQ:AIH) among the top gainers. Conversely, View, Inc. (NASDAQ:VIEW) and Acorda Therapeutics, Inc. (NASDAQ:ACOR) led the pre-market losers.

Portfolio Pulse from Avi Kapoor

April 03, 2024 | 12:11 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.